| 產(chǎn)品編號(hào) | bs-48036P |
| 英文名稱(chēng) | Recombinant human EPO protein (Active, HEK293) |
| 中文名稱(chēng) | 重組人促紅細(xì)胞生成素C-hFc（活性的） |
| 別 名 | EPO_HUMAN; Erythropoietin; Epoetin; EP; DBAL; ECYT5; MVCD2; 人促紅細(xì)胞生成素; 人促紅細(xì)胞生成素重組蛋白; 重組人促紅細(xì)胞生成素; 人重組人促紅細(xì)胞生成素; 重組人EPO; |
| 檢測(cè)分子量 | 54-67 kDa |
| 性 狀 | Lyophilized powder |
| 濃 度 | ＞0.5 mg/ml |
| 物 種 | Human |
| 序 列 | 1-193/193 |
| 純 度 | >95% as determined by SDS-PAGE |
| 純化方法 | AC |
| 內(nèi)毒素 | <0.5 EU/μg as determined by LAL. |
| 表達(dá)系統(tǒng) | HEK293 cell |
| 活性 | Yes |
| 標(biāo)簽 | Tag free |
| 保存條件 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. In general: 12 months from date of receipt, -20 to -80℃ as supplied. 1 month, 2 to 8℃ under sterile conditions after reconstitution. 3 months, -20 to -80℃ under sterile conditions after reconstitution. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 | Erythropoietin is a member of the EPO / TPO family. It is a secreted, glycosylated cytokine composed of four alpha helical bundles. Erythropoietin can be found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis. It also has neuroprotective activity against a variety of potential brain injuries and antiapoptotic functions in several tissue types. Erythropoietin is the principal hormone involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. It is produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals. Genetic variation in erythropoietin is associated with susceptbility to microvascular complications of diabetes type 2. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. It has a longer circulating half-life in vivo. Erythropoietin is being much misused as a performance-enhancing drug in endurance athletes. SWISS: P01588 Gene ID: 2056 |
我要詢(xún)價(jià)
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話(huà)等，您的聯(lián)系方式不會(huì)被公開(kāi))
*內(nèi)容：
